Follmann et al: study shows us that the vaccine is DAMAGING our natural immunity (reduced antibodies to the nucleocapsid 'more stable conserved protein in SARS-2 virus); MODERNA trial

by Paul Alexander

"Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial"; shows that vaccine constrains N-Abs natural immunity

MODERNA trial.


Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial

This paper is not yet peer-reviewed. It was a study of the MODERNA vaccine and they looked at the N protein (nucleocapsid) antibody (Ab) levels and they examined it in vaccine versus placebo groups. In those at risk of infection and who were not prior infected, and were vaccinated vs not vaccinated, then became infected, they looked at the immune system N-protein Ab response in both groups (vaccine vs no vaccine).

A Multicenter, randomized, double-blind, placebo-controlled trial at 99 sites in the US. “Nested analysis in a Phase 3 randomized, placebo-controlled vaccine efficacy trial. Nasopharyngeal swabs for SARS-CoV-2 PCR testing were taken from all participants on Day 1 and Day 29 (vaccination days), and during symptom-prompted illness visits. Serum samples from Days 1, 29, 57, and the Participant Decision Visit (PDV, when participants were informed of treatment assignment, median day 149) were tested for anti-N Abs.”

Researchers looked at data from 1,789 participants (1,298 in the placebo arm and 491 in the vaccine arm); SARS-CoV-2 infection during the blinded phase. They reported that

“Among participants with PCR-confirmed Covid-19 illness, seroconversion to anti-N Abs at a median follow up of 53 days post diagnosis occurred in 21/52 (40%) of the mRNA-1273 vaccine recipients vs. 605/648 (93%) of the placebo recipients (p < 0.001).”

The study is alarming in that it shows that those who were vaccinated and infected had a much lower (statistically) ability to develop an immune response to the N protein (more conserved) than those who were not vaccinated, 40% vs 93%. This on top of the fact that the vaccine has been shown to be highly ineffective, is driving massive infection in the vaccinated, and is causing appreciable hospitalization and death in the vaccinated.

If the N-protein immune response is damaged (natural acquired-adaptive immunity or immune memory), then with the constant new variants due to the non-sterilizing vaccine that does not stop infection or transmission (and natural selection selecting for the fittest competitively advantaged variants), one would be at risk for repeated infection. There is constant infectious pressure as we are in the midst of circulating virus. Driven in large part now by the failed vaccine.

One would be at risk not only to COVID re-infections, but from other pathogen coming alive, other latent infection also. Here is where original antigenic sin is operating (OAS) for the initial prejudice or imprinting or priming of the immune system biases it towards the prior strains/variants. In this case the recall immunity (Abs) is to the initial or prior strains/variants, and not the existing strain/variant. In short, the N-protein Abs are depressed if one is infected post COVID injection. This is what the data is showing.

One is also to expect that elderly persons as an example, with an already compromised immune system (immunosenscence due to aging), if their sub-optimal immunity is being further subverted with vaccine, then they will show much higher illnesses. We can expect as rise.